[Peptides prevent the forming of secretory phenotype of chondrocytes associated with the aging.]

Area of Science:

• Molecular gerontology
• Cellular senescence
• Biochemistry of aging

Context:

• Aging chondrocytes exhibit a secretory phenotype (SASP), contributing to musculoskeletal diseases such as osteoarthritis (OA).
• Identifying effective OA treatments is a critical challenge in molecular gerontology.
• SASP involves altered expression of key proteins and cytokines.

Purpose:

• To characterize the secretory phenotype associated with aging (SASP) in chondrocytes.
• To comparatively assess the effects of AED peptide and cartilage polypeptide complex (CPC) on chondrocyte SASP.
• To explore the therapeutic potential of AED peptide and CPC for OA and related musculoskeletal conditions.

Summary:

• Chondrocyte SASP is marked by increased pro-apoptotic proteins (p16, p21, p53), pro-inflammatory cytokines (TNF-α, IL-1α), and decreased Sirt1 synthesis.
• Both AED peptide and cartilage polypeptide complex (CPC) were found to normalize the synthesis of molecules involved in chondrocyte SASP.
• These normalizing effects suggest a geroprotective mechanism for AED and CPC.

Impact:

• The findings provide insights into the molecular mechanisms underlying OA pathogenesis.
• AED peptide and CPC demonstrate potential as therapeutic agents for OA and other musculoskeletal disorders.
• This research contributes to the development of novel geroprotective strategies for age-related diseases.